REQUEST A DEMO
Total
USD $0.00
Search more companies

Bestpharma Sp. z o.o. (Poland)

Main Activities: Chemical and Allied Products Merchant Wholesalers
Full name: Bestpharma Sp. z o.o. Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

bestpharma is a pharmaceutical and veterinary industry company. They offer a wide range of products and solutions, including natural extracts, fruit powders, enzymes, coatings, oils, and collagens. bestpharma provides support at every stage of production and focuses on sustainability, offering high-quality raw materials for pharmaceutical and veterinary supplements manufacturers. They are continuously researching and expanding their offerings with innovative solutions.

Headquarters
Ul. Targowa 67/6A
Warsaw; Mazowieckie; Postal Code: 03-729

Contact Details: Purchase the Bestpharma Sp. z o.o. report to view the information.

Website: http://www.bestpharma.pl

Basic Information
Total Employees:
Purchase the Bestpharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Bestpharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bestpharma Sp. z o.o. report to view the information.
Incorporation Date:
December 31, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
82%
Company Performance
Financial values in the chart are available after Bestpharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
70.34%
Total operating revenue
70.79%
Operating profit (EBIT)
-16.97%
EBITDA
-14.2%
Net Profit (Loss) for the Period
-54.04%
Total assets
26.82%
Total equity
29.6%
Operating Profit Margin (ROS)
-3.6%
Net Profit Margin
-4.22%
Return on Equity (ROE)
-41.56%
Debt to Equity Ratio
42%
Quick Ratio
-0.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?